PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Aug 10, 2026, 2:22 AM

Dr Reddy’s to discontinue marketing of Novartis in-licensed brands from October

In an intimation to the stock exchange, the company said it had terminated the agreement signed between the two companies for the distribution and promotion of select brands in India.

ET Pharma

Aug 10, 2026, 1:02 AM

Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenue

The agreement covers 55 SKUs to be manufactured across three Gland Pharma sites, with scope for additional products to be added. Once the portfolio is fully commercialised, the agreement is expected to have an annualised revenue potential of approximately $90 million-$100 million.

ET Pharma

Aug 10, 2026, 1:01 AM

Nearly 200 deaths linked to weight-loss drugs Ozempic and Mounjaro in the UK

According to the MHRA Yellow Card scheme, which allows healthcare professionals, the public, and pharmaceutical companies to report the side-effects of drugs, there have been 59 deaths linked to semaglutide, which is known by the brand names Ozempic and Wegovy. Eleven of these deaths were cardiac disorders.

ET Pharma

Aug 8, 2026, 4:49 PM

Acute therapy sales surge in July as Monsoon intensifies

Over the past month, most segments within the acute therapy market reported a positive uptick, in line with the seasonal disease pattern. Antihistamines, which are used to treat allergies such as sneezing and runny nose hit a record reaching their highest level since January 2022.

ET Pharma

Aug 8, 2026, 11:29 AM

Semaglutide generics regain momentum in July — but few brands lead the charge

The revival remains concentrated among a few companies, with 11 of the 33 brands accounting for 80 per cent of total sales volume. Leading the charge was Dr Reddy’s Obeda, whose sales more than doubled to 1.15 lakh units from 55,000 units in June.

ET Pharma

Aug 8, 2026, 2:30 AM

Gland Pharma, Neuland enter into long-term sterile API CDMO partnership

Under the agreement, Gland Pharma will build a dedicated sterile manufacturing suite at its JNPC facility in Visakhapatnam to support Neuland’s rising requirements for sterile APIs used in microparticle depot products and other complex sterile ingredients.

News

Latest industry coverage

Google News

Aug 10, 2026, 3:58 AM

Simcere Pharmaceutical Group (SEHK:2096) Guidance Puts Valuation Back In Focus - simplywall.st

Simcere Pharmaceutical Group (SEHK:2096) Guidance Puts Valuation Back In Focus  simplywall.st

Google News

Aug 10, 2026, 3:29 AM

Stocks to Watch Today: Titan, Oil India, Signature Global, Emcure Pharma, RITES, Anawil Wire, Anant Raj,... - Moneycontrol.com

Stocks to Watch Today: Titan, Oil India, Signature Global, Emcure Pharma, RITES, Anawil Wire, Anant Raj,...  Moneycontrol.com

Google News

Aug 10, 2026, 3:22 AM

'In the next few years, many products will come out of India that will globally help patients' - manifest-media.in

'In the next few years, many products will come out of India that will globally help patients'  manifest-media.in

Google News

Aug 10, 2026, 2:55 AM

Peptide fans blame big pharma for a lack of data. Here’s the truth - AFR

Peptide fans blame big pharma for a lack of data. Here’s the truth  AFR

Google News

Aug 10, 2026, 2:19 AM

Tyros Biopharma Accelerates Expansion of Women’s Health Portfolio With Four New Product Introductions in 2026 - BioSpace

Tyros Biopharma Accelerates Expansion of Women’s Health Portfolio With Four New Product Introductions in 2026  BioSpace

Google News

Aug 10, 2026, 12:07 AM

Jitendra Singh: India Poised to Lead AI and Biotechnology-Driven Industrial Revolution - Daily Pioneer

Jitendra Singh: India Poised to Lead AI and Biotechnology-Driven Industrial Revolution  Daily Pioneer

Google News

Aug 10, 2026, 12:00 AM

Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections - Yahoo Finance Singapore

Second PIC/S GMP Certification | Mabwell Passes Brazilian GMP Inspection for Its Denosumab Injections  Yahoo Finance Singapore

Google News

Aug 9, 2026, 11:31 PM

Shanghai Henlius Biotech (SEHK:2696) Advances Oncology Pipeline, Is It Still 64% Below Fair Value? - simplywall.st

Shanghai Henlius Biotech (SEHK:2696) Advances Oncology Pipeline, Is It Still 64% Below Fair Value?  simplywall.st

Google News

Aug 9, 2026, 11:19 PM

A shortage of two Sanofi medicines for Pompe disease rattles patients - statnews.com

A shortage of two Sanofi medicines for Pompe disease rattles patients  statnews.com

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer